Member Info for inanaco

retired .. sorry

agree to disagree ... sorted.

Point being again that its not something Scancell has the power over ...

Try it yourself ... To get onto the BBC you need to be a tired Russian war veteran capable of Knitting Socks and running a marathon ... in your leaving room

or

if you are a Professor caught with your pants down ....

when you are having to defend a share by comparing how crap other shares are ... as a defense ... just tells you how crap you consider your own share is ...

its digital only ........ no staff involved

other banks don't have its customers going online and complaining ..............

Barclays has cut to the bone and has no resilience in the system .. the end result is Bad PR ... and angry customers .

unfortunately over time that hits the bottom line ... and then affects shareholders

resulting in further cost cutting and shrinkage and quality customers leaving ...

https://www.bbc.co.uk/news/business-52542037

really .. ?

TF ....

Scancell does not control the airways ....

if the "News" moves to restarting the economy ... the long boring stuff of developing a vaccine loses "Impact" ... and is not taken up by the Stack them High and Scare the Public ... Broadcasters

"" two BBC clips and the media bits, really do not add up to a coordinated media response""

so if the main channel BBC does not take i up ........... not a lot Scancell can do

Ivy ............. Immunobody itself is a fully humanised antibody .... it is a MAB ... against Covid ...

Ivy ....
Cancer is alive

the virus is dead without a host cell ..

you don't need to kill it only block its path into a cell ..

now the young may get the vaccine .............. but hang on they get old ..

what happens to that immunity ?

if its only antibodies ... well not that effective

if the full adaptive immune system is involved ............ well that is very effective

if you add the extra Zip from Cross presentation ........... The Holy Grail is back ...

a Potent response that your body itself could not mount against cancer ............ think about it

case rested

so the issue is Potency ...

because you are not interested in protecting the young .......... because they have little issues dealing with the Virus ..

but you have to build a response for the old ....

so the response in the Old is far more important to get a potent response than the young ... now this is the area that many vaccines will fail.

the young will get a vaccine that works but the vaccine will fail in the over 55 groups ..

This is what Lindy is betting on ........... and i would as well .. hence i hold shares

Ivy i did not say i would not work, i asked why would you need it ...

The problem has been raised many times about long term immunity ... so if the infection only generates a weak immune response which clearly it does as many dont know they have had the infection, then that infection maybe short lived being only antibodies ..

so Vaccines are capable of mobilizing various responses even higher than the decease itself was capable of ,...

ie you will not have "Potent High Avidity T cells" in your Armour ...

but you will if you have a memory induced response from an immunobody vaccine ...

with a cancer cell its different the MAB can lock on .. but the cell is still active .... so the MAB has to call in others to kill or punch a hole in the cell membrane to kill it ...

the virus itself is dead ... its not living

neutralising ........ ie its ineffective ... in that case the virus is nothing without a host cell what are you trying to Kill Ivy .. ?

which EU ... thought they had two ....... and it moved by train ...

Barclays software does not work ... just comes up with Error Code

whats on hold Ivy that affects the research staff ?

still the Mcap is only £42m

Don't forget SCIB1 for melanoma trial hopefully will get started soon with Keytruda

SCIB2 ... lets hope CRUK has sent if of for manufacture and then that trial can get started with Keytruda

we are waiting for the 3rd conjugate to be manufactured again for the Modi1 program lets hope we hear some thing soon on that front

we are waiting the outcome of the TCR program with BioNtech

we are waiting on the 3 avidmab collaborations ..

we Now have CoVidity ...

Scancell is not a one trick pony ...................

Modi2 should be getting close as well .....

what has NCYT got to do with scancell ? do they make vaccines

the issue is not the cost of a vaccine for the west its the cost of a vaccine to Yemen ..